Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US. It is led by Leonard S. Schleifer M.D., Ph.D..
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Use this REGN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the REGN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the REGN SEC filings page. Lician reads the product cache first so this HTML stays unique to Regeneron Pharmaceuticals Inc even when a live quote feed is slow.
Latest cached year on this hub. Full REGN income, balance, and cash tables.